Symptoms | SVV viremia (PCR) | Immune status during SVV outbreak | Treatment of SVV | Follow up | |
---|---|---|---|---|---|
R1 | Fever Vesicular skin rash Anorexia Vomiting | + | Immunosuppression for islet TPL | Ganciclovir Cefazolin Ibuprofen Adalimumab Maropitant citrate | ↑AST and ALT Death 3 days after the onset of symptoms |
R2 | Fever Vesicular skin rash Anorexia | + | Immunosuppression for islet TPL | Ganciclovir Cefazolin Ibuprofen Adalimumab | Disappearance of rash 5 days after the onset of symptoms Recovery |
R3 | Fever Vesicular skin rash | + | Immunocompetence | Ganciclovir IV SID Cefazolin Ibuprofen | Disappearance of rash 6 days after the onset of symptoms Recovery |
R4 | Vesicular skin rash Vomiting | + | Immunocompetence | Ganciclovir IV SID Cefazolin Maropitant citrate | Disappearance of rash 6 days after the onset of symptoms Recovery |
R5 | – | + | Immunosuppression for islet TPL | Prophylactic use of ganciclovir | SVV viremia detected but no symptoms by prophylactic use of ganciclovir |
R6 | – | + | Immunocompetence | Prophylactic use of ganciclovir | SVV viremia detected but no symptoms by prophylactic use of ganciclovir |
R7 | – | – | Immunosuppression for islet TPL | Prophylactic use of ganciclovir | |
R8 | – | – | Immunocompetence | Prophylactic use of ganciclovir | |
R9 | – | – | Immunosuppression for islet TPL | Prophylactic use of ganciclovir | |
R10 | – | – | Immunosuppression for islet TPL | Prophylactic use of ganciclovir | |
R11 | – | – | Immunocompetence | Prophylactic use of ganciclovir | |
R12 | – | – | Immunocompetence | Prophylactic use of ganciclovir | |
R13 | – | – | Immunocompetence | Prophylactic use of ganciclovir | |
R14 | – | – | Immunocompetence | Prophylactic use of ganciclovir |